Start for free
Start for free
AP

Ample Plus Fund

Description

Ample Plus Fund

Investor Profile

Ample Plus Fund has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (67%)
  • United Kingdom (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Alternative Medicine
  • Precision Medicine
  • Pharmaceutical
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ample Plus Fund frequently co-invest with?

Irving Investors
Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 1
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Eventide
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 2
Blackstone Life Sciences
Blackstone Life Sciences
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Green Sands Equity
Green Sands Equity
North America, California, United States, San Francisco
Co-Investments: 1
OCV
OCV
North America, California, United States, Los Angeles
Co-Investments: 1
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
Avoro Capital Advisors
Avoro Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Point72 Ventures
Point72 Ventures
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Ample Plus Fund?

Cyteir Therapeutics

Cambridge, Massachusetts, United States

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

BiopharmaBiotechnologyPharmaceutical
Series CFeb 11, 2021
Amount Raised: $80,000,000
Praxis Precision Medicines

Cambridge, Massachusetts, United States

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Alternative MedicineBiotechnologyHealth CareMedicalPrecision Medicine
Series CJul 28, 2020
Amount Raised: $110,000,000
Freeline

Stevenage, Herefordshire, United Kingdom

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

BiopharmaBiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CJun 30, 2020
Amount Raised: $80,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator